Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference22 articles.
1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin.,2016
2. National failure to operate on early stage pancreatic cancer;Bilimoria;Ann Surg.,2007
3. Pancreatic adenocarcinoma;Ryan;N Eng J Med.,2014
4. CA19-9-Low&Lewis (+) pancreatic cancer: a unique subtype;Luo;Cancer Lett.,2017
5. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma;Ghaneh;Ann Surg.,2019
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circulating tumor DNA (ctDNA) application in investigation of cancer: Bench to bedside;Archives of Biochemistry and Biophysics;2024-08
2. Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and liver recurrence highlighting biological heterogeneity;Surgical Oncology;2024-08
3. Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma;The Oncologist;2024-07-17
4. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma;Scientific Reports;2024-07-13
5. Serplulimab combined with gemcitabine, nab-paclitaxel and stereotactic body radiotherapy as the first-line treatment for patients with metastatic pancreatic adenocarcinoma in China: a multicentre, single-arm, phase II trial (ICSBR) protocol;BMJ Open;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3